| Literature DB >> 32326364 |
Jillian Hill1, Nasheeta Peer1, Deborah Jonathan1, Mary Mayige2, Eugene Sobngwi3, Andre Pascal Kengne1.
Abstract
Completed and ongoing implementation activities globally advocate for community-based approaches to improve strategies for type 2 diabetes prevention. However, little is known about such strategies in the African region where there are higher relative increases in diabetes prevalence. We reported findings from the first 8-month pilot phase of the South African diabetes prevention program. The study was conducted across eight townships (four black and four mixed-ancestry communities) in Cape Town, South Africa, between August 2017 and March 2018. Participants were recruited using both random and self-selected sampling techniques because the former approach proved to be ineffective; <10% of randomly selected individuals consented to participate. Non-laboratory-based diabetes risk screening, using the African diabetes risk score, and based on targeted population specific cut-offs, identified potentially high-risk adults in the community. This was followed by an oral glucose tolerance test (OGTT) to confirm prevalent pre-diabetes. Among the 853 adults without prior diabetes who were screened in the community, 354 (43.4%) were classified as high risk, and 316 presented for further screening. On OGTT, 13.1% had dysglycemia, including 10% with screen-detected diabetes and 67.9% with glycated haemoglobin (HbA1c)-defined high risk. Participants with pre-diabetes (n = 208) had high levels of common cardiovascular risk factors, i.e., obesity (73.7%), elevated total cholesterol (51.9%), and hypertension (29.4%). Self-referral is likely an efficient method for selecting participants for community-based diabetes risk screening in Africa. Post-screening management of individuals with pre-diabetes must include attention to co-morbid cardiovascular risk factors.Entities:
Keywords: cardiovascular disease; community screening; diabetes risk; dyslipidemia; hypertension
Mesh:
Substances:
Year: 2020 PMID: 32326364 PMCID: PMC7215538 DOI: 10.3390/ijerph17082876
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Area demographics of included communities.
| Area | Total Population | Level of Education | Average Income | Number of Schools | Number of Health Facilities |
|---|---|---|---|---|---|
| Khayelitsha SP | 11,251 (2357.23/km2) | No info | No info | No info | No info |
| Belhar | 56,234 (6882.25/km2) | No schooling aged 20 + (1.4%). | Average household income: | ±20 | 2 (St Vincent clinic and Chestnut CHC) |
| Athlone | 8893 (5900/km2) | 71.9% completed grade 9 or higher. | Average household income: | ±20 | 6 (Hood road medical center, Dr. Abdurahman day hospital, Samwumed, Fresenius medical care and Athlone kidney and Dialysis center, Al-nisa maternity home, and Kromboom dental center) |
| Bongweni | 1791 (9420.58 per km2) | No info | No info | ±11 to 15 | 3 (Khayelitsha community health clinic, Clinimed medical and asthetic solutions, and mens clinic international) |
| Lavender hill | 26,372 (9335.6/km2) | 62.3% completed grade 9 or higher. | Average annual income = R57,500 | ±7 | 2 (Lavender hill clinic and Sea wind CHC–TB unit) |
| Gugulethu | 98,468 (15,161.70/km2) | 78.2% completed grade 9 or higher. | Average household income: | ±20 | 2 (Gugulethu medical center and KTC Gugulethu CHC) |
| DuNoon | 29,268 (29,518.5/km2) | 70.7% completed grade 9 or higher. | Average monthly income = R2400 | 5 | 1 (DuNoon CHC) |
| Lotus river | 38,143 (7615.72/km2) | 74.8% completed grade 9 or higher. | Average annual income = R57,500 | ±10–15 | 2 (Lotus river community health clinic and lotus river public clinic) |
Sources: Total population data—Census2011.adrianfrith.com [14]; Level of education data for Athlone, Lavender hill, Gugulethu, Dunoon, Lotus river—WaziMap.co.za [15]; Level of education for Belhar—Statssa.gov.za [16]; Average household income data for Belhar, Athlone, Gugulethu—Statssa.gov.za; Average annual income data for lotus river, Lavender hill, Dunoon—WaziMap.co.za [15]; Number of schools and number of health facilities data—Google maps [17]. CHC—community health center; TB—tuberculosis.
Figure 1Community-based screening group comparison.
The African diabetes risk score, in those without prior diabetes. SADPP, South African diabetes prevention program.
| SADPP Risk Score Calculation | |
|---|---|
| Regression coefficients of the model | |
| Variable | Coefficient |
| Age (per 1-year increase) | 0.045 |
| Waist Circumference (per cm increase) | 0.048 |
| Hypertension (present (1) vs. absent (0)) | 0.649 |
| Intercept | −11.012 |
Diabetes score = 100 × (1 ÷ (1 + exp (−(−(11.012) + 0.045 × A+0.048 × ((B + C) ÷ 2) + 0.649 × (D))))). Where A–Age, B–Waist circumference 1 in cm, C–Waist circumference 2 in cm, D–Hypertension: Yes, if Systolic = 140 or more or Diastolic = 90 or more or if self-reported history of doctor diagnosed hypertension. Participants with a score >1.46 (Black) or >1.15 (mixed ancestry).
Measurement domains, tools, and data collection for the South African Diabetes Prevention Programme (SADPP) pilot phase.
| Variable | Components | Measurements Tools/Questions | Reporting in this Paper |
|---|---|---|---|
|
| Personal details and contacts for follow up | Not reported | |
|
| Age, gender, area, community, current marital status, education level, employment, income | Reported | |
|
| General | Not reported | |
| Chronic diseases | Diabetes, hypertension, cholesterol, bronchitis/chronic obstructive pulmonary disease, cancer, tuberculosis | Not reported | |
| Heart health | Jackson heart medical form [ | Not reported | |
| medication | Chronic prescription medication | Not reported | |
| Family medical history | Hypertension, diabetes, heart attack, stroke, cancer | Only familial diabetes history reported | |
|
| Tobacco use | WHO STEPS questionnaire [ | Reported |
| Alcohol use | WHO STEPS questionnaire [ | Reported | |
| Sedentary behavior | Time spent in front of a screen | Reported elsewhere [ | |
| Sleep | Time, quality | Reported elsewhere [ | |
|
| 24-hour dietary recall Barriers to healthy eating | Single unquantified dietary recall [ | Not reported |
|
| Physical activity pattern | WHO STEPS questionnaire: global physical activity questionnaire (GPAQ) [ | Reported elsewhere [ |
| Barriers to physical activity | Scale adapted from the one designed by Booth et al. [ | Reported elsewhere [ | |
| Self-efficacy | Scale adapted from the exercise self-efficacy scale (ESES) designed by Schwarzer and Jerusalem [ | Reported elsewhere [ | |
|
| Waist circumference | Measured between the lower border of the lowest rib and upper border of the iliac crest/pelvic bone to the nearest 0.1 cm | Reported |
| Weight | Weight measurement with minimal clothing on a digital (SECA) scale, recorded to the nearest 0.1 kg | Reported (BMI) | |
| Height | Standing height, minimal clothing, aligning head in a standard anatomical position using a SECA stadiometer | ||
| SBP | Electronic M6 COMFORT OMRON device with an integrated cuff | Reported | |
| DBP HbA1c | Electronic M6 COMFORT OMRON device with an integrated cuff HbA1c measured using fasting blood and HPLC | Reported | |
|
| Stores and facilities, access to services and places, roads and walking paths, places for walking/cycling/playing, surroundings, safety from crime and traffic, personal safety, stranger danger | Neighborhood environment walkability scale (NEWS) Africa Questionnaire [ | Reported elsewhere [ |
|
| Chronic stress | Chronic stress scale [ | Reported elsewhere [ |
| Mood (depression and anxiety) | Patient health questionnaire-9 amended in line with CURES-65 study [ | Not reported | |
| Support networks | ENRICHD social support scale [ | Not reported | |
| Quality of life | The MOS 36-item short-form health survey [ | Not reported | |
| Life satisfaction | How satisfied are you with your life as a whole? | Not reported |
Adapted from Hill et al. 2020 [21]. WHO—World Health organization; BMI—body mass index; SBP—systolic blood pressure; DBP—diastolic blood pressure; HbA1c—glycated haemoglobin; HPLC—high-performance liquid chromatographic.
Characteristics of community screened participants.
| Characteristic |
| % | |
|---|---|---|---|
| Ethnicity | Black | 432 | 52.9 |
| Mixed ancestry | 385 | 47.1 | |
| Sex | Males | 189 | 23 |
| Females | 648 | 77 | |
| Mean age (years) | 47.3 (10.6 SD) | ||
| Older than 45 | Yes | 512 | 61.2 |
| Township | Athlone ** | 85 | 10.4 |
| Belhar ** | 145 | 17.4 | |
| Bongweni/Tembani * | 19 | 2.4 | |
| Du Noon * | 49 | 5.7 | |
| Gugulethu * | 239 | 28.3 | |
| Khayelisha SP * | 133 | 15.7 | |
| Knole park/Lotus river ** | 75 | 8.9 | |
| Lavender hill ** | 86 | 10.2 | |
| Body mass index | Underweight | 27 | 3.3 |
| Normal weight | 181 | 22.3 | |
| Overweight | 208 | 25.6 | |
| Obese | 396 | 48.8 | |
| Mean waist circumference (cm) | 94 (21.9 SD) | ||
| BP ≥ 140/90 mmHg or known hypertension | Yes | 198 | 24.2 |
| Family history of diabetes | Yes | 244 | 29.2 |
| At risk for diabetes | Yes | 354 | 43.4 |
* Black; ** Mixed ancestry.
Socio-demographic characteristics of participants who presented for clinic screening.
| Socio-Demographic Characteristics ( | ||||
|---|---|---|---|---|
| General Population | Black 177 (54.2%) | Mixed-Ancestry 141 (45.7%) | ||
| Age, mean (SD) | 51.8 (8.9) | 49 (9.5) | 54 (7.7) ** | |
| Gender |
| % | ||
| Male | 60 | 19.0 | 30 (17.5) | 30 (20.8) |
| Female | 253 | 80.1 | 141 (82.5) | 114 (79.5) |
| NA | 3 | 0.9 | ||
| Education | ||||
| Never went to school | 2 | 0.6 | 1 (0.6) | 1 (0.7) |
| Primary school (grades 1–7) | 76 | 24.1 | 36 (21.4) | 41 (28.3) |
| High school (grades 8–12) | 136 | 43.0 | 67 (39.9) | 69 (47.6) * |
| Less than grade 12 + FET*/certificate/diploma | 11 | 3.5 | 6 (36.) | 5 (3.4) |
| Grade 12 | 36 | 11.5 | 20 (11.9) | 16 (11) |
| Tertiary/diploma/degree | 51 | 16.3 | 38 (22.6) | 13 (9) * |
| Not Assigned | 5 | 1.6 | ||
| Occupation | ||||
| Employed (full- or part-time/self-employed) | 93 | 29.4 | 53 (29.9) | 40 (28.6) |
| Unemployed | 133 | 42 | 87 (49.1) | 46 (32.8) |
| Full-time homemaker | 21 | 6.6 | 2 (1.1) | 19 (13.5) |
| Pensioner | 58 | 18.4 | 21 (11.9) | 37 (26.2) |
| On a disability grant | 13 | 4.1 | 5 | 8 |
| Child grant | 4 | 1.3 | 3 | 1 |
| Income | ||||
| No income | 32 | 10.2 | 23 (13.7) | 9 (6.2) ** |
| R1–R400 | 12 | 3.8 | 12 (7.1) | 0 |
| R401–R800 | 27 | 8.6 | 18 (10.7) | 9 (8.6) |
| R801–R1600 | 75 | 24 | 41 (24.4) | 34 (23.4) ** |
| R1601–R3200 | 95 | 30.4 | 51 (30.4 | 44 (30.3) |
| R3201–R6400 | 42 | 13.2 | 16 (9.5) | 26 (17.9) ** |
| R6401–R12,800 | 19 | 6.1 | 4 (2.4) | 15 (10.3) ** |
| R12,801–R25,600 | 10 | 3.2 | 3 (1.8) | 7(4.8) ** |
| R25,601–R51,200 | 1 | 0.3 | 0 | 1 (0.7) |
FET*–Further education and training. * p-value < 0.5; ** p-value ≤ 0.001.
Health and behavioral risk factors among participants who presented for clinic screening.
| Risks Factors ( | ||||
|---|---|---|---|---|
| General Population | Black | Mixed-Ancestry | ||
| Body Mass Index (BMI, kg/m2), mean (SD) | 36 (7.7) | 36.9 (8.3) | 35.1 (6.9) | |
| Waist circumference (cm), mean (SD) | 104 (13.2) | 103.9 (13.9) | 104.4 (12.5) | |
| BMI |
| % | ||
| Underweight (<18.5) | X0 | 0 | 0 | 0 |
| Normal weight (18.5–24.9) | 12 | 3.8 | (4.1) | (3.6) |
| Overweight (25.0 to 29.9) | 67 | 21.2 | (21.6) | (20.1) |
| Obese | 233 | 73.7 | (74.3) | (76.3) |
| Not documented | 4 | 1.3 | ||
| Family medical history | ||||
| Having at least one known diabetic close relative | 141 | 44.6 | 70 (40.9) | 71 (49.7) |
| Don’t have one known diabetic close relative | 57 | 18.0 | 99 (57.9) | 68 (47.6) |
| Don’t know | 114 | 36.1 | 2 (1.2) | 4 (2.8) |
| Not documented | 4 | 1.3 | ||
| Blood pressure | ||||
| Optimal/normal (<120/120–129 mmHg/<80/80–84 mmHg) | 129 | 40.8 | (35.7) | (47.5) * |
| High normal (130–139 mmHg/85–89 mmHg) | 71 | 22.5 | (25.7) | (19.4) * |
| Hypertension (≥140 mmHg/90 mmHg) | 93 | 29.4 | (33.3) | (25.9) * |
| Isolated systolic hypertension (≥140 mmHg/<90 mmHg) | 19 | 6.0 | (5.3) | (7.2) * |
| Not documented | 4 | 1.3 | ||
| Glycosylated hemoglobin (HbA1c) | ||||
| ≥5.7 mmol/L | 208 | 67.9 | 104 (62.3) | 104 (74.3) * |
| Not documented | 11 | 3.5 | ||
| Glycemia | ||||
| Impaired fasting glucose (>6.1–7 mmol/L) | 18 | 5.8 | 10 (5.9) | 8 (5.8) |
| Impaired glucose tolerance (≥7.8–11.1 mmol/L) | 41 | 13.2 | 22 (12.9) | 19 (13.7) |
| Diabetic (IFG >7 mmol/L and IGT >11.1 mmol/L) | 31 | 10 | 15 (8.8) | 16 (11.3) |
| Cholesterol | ||||
| Total cholesterol (>5 mmol/L) | 150 | 48.2 | 68 (40) | 82 (58.2) ** |
| HDL cholesterol (<1.2 mmol/L) | 166 | 52.9 | 79 (47) | 85 (60.3) * |
| LDL cholesterol (>3 mmol/L) | 179 | 57.7 | 78 (47.6) | 99 (70.2) ** |
| Triglycerides (>1.5 mmol/L) | 113 | 35.8 | 47 (27.6) | 63 (44.7) ** |
| Alcohol consumption | ||||
| Abstainer | 174 | 54.8 | 78 (45.3) | 98 (65.8) ** |
| Less than once a month | 51 | 15.9 | 32 (18.6) | 19 (12.8) ** |
| 1–3 days per month | 45 | 14 | 30 (17.4) | 15 (10.1) ** |
| Several times per week | 42 | 13.1 | 31 (18.0) | 11 (7.4) ** |
| Not documented | 7 | 2.2 | ||
| Tobacco status | ||||
| Non-smoker | 191 | 59.95 | 125 (72.7) | 66 (44.3) ** |
| Current smoker (daily or occasionally) | 109 | 34 | 36 (20.9) | 73 (49) ** |
| Ex-smoker | 14 | 4.4 | 10 (5.8) | 4 (2.7) ** |
| Not documented | 7 | 2.2 | ||
* p-value < 0.5; ** p-value ≤ 0.001; cm—centimeter; IFG—impaired fasting glucose; IGT—impaired glucose tolerance; HDL—high-density lipoprotein; LDL—low-density lipoprotein.
Significant differences in cardiovascular disease (CVD) risk factors and glycemic status.
| Glycemic Status | Normoglycemia ( | Dysglycemia ( | Diabetic ( | |
|---|---|---|---|---|
| (IFG < 6 and IGT < 7.8) | (IFG > 6.1–7 mmol/L and IGT ≥ 7.8–11.1 mmol/L) | (IFG > 7 mmol/L and IGT > 11.1 mmol/L) | ||
| HbA1c (≥5.7 mmol/L) | 142 (59.4) | 32 (78) | 31 (100) | <0.0001 |
| Total cholesterol (>5 mmol/L) | 116 (48.5) | 16 (39) | 15 (46.8) | 0.525 |
| HDL cholesterol (<1.2 mmol/L) | 84 (35) | 19 (46.3) | 15 (46.8) | 0.159 |
| LDL cholesterol (>3 mmol/L) | 122 (51) | 19 (46.3) | 19 (59.4) | 0.544 |
| Triglycerides (>1.5 mmol/L) | 77 (32.2) | 16 (39) | 15 (46.8) | 0.169 |
| BMI (overweight and obese) (>25 kg/m2) | 229 (95.8) | 39 (95.1) | 30 (93.8) | 0.484 |
| Hypertension (≥140 mmHg/90 mmHg) | 80 (33.5) | 16 (39) | 13 (40.6) | 0.524 |
IFG—Impaired fasting glucose; IGT—impaired glucose tolerance; HDL—high-density; HDL—lipoprotein; LDL—low-density lipoprotein; BMI—body mass index.